Associations Between Urinary Metabolic Indicators and Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis: Evidence from National Health and Nutrition Examination Survey 2017-2020.
Background/Aims Metabolic dysfunction-associated steatotic liver disease (MASLD) reflects the central role of systemic metabolic disturbances in the pathogenesis of fatty liver. Urinary metabolic indicators may capture integrated renal, inflammatory, and metabolic alterations associated with MASLD and liver fibrosis....